NCT04139785

Brief Summary

Depression is a common condition and is the leading cause of disability worldwide. Preventing or delaying the onset of depression is an important way to reduce the burden of depression. Some research suggests online methods may be effective in preventing depression, but to date, few studies have looked at the application of these methods in the UK. This study aims to assess the effects of an online self-help intervention (Moodbuster) on preventing depression in a primary care population, who are experiencing mild-moderate symptoms of depression, but do not meet the threshold for diagnosis. A randomised control design with a six-month and nine-month follow up will be used to compare Moodbuster to a wait-listed control group. Then, a qualitative process evaluation will be used to understand the barriers and facilitators of implementing the intervention. Eligible participants in Greater Manchester (individuals with mild to moderate symptoms of depression, who do not have a diagnosis of major depressive disorder and have access to the internet) will take part in a 6-week online self-help programme, accompanied by three telephone calls with a trained researcher to support them in their use of the programme. Researchers will follow-up with participants six and nine months after starting the programme to measure depression, anxiety, quality of life, and use of services. The process evaluation will involve qualitative interviews with participants and focus groups with practitioners who referred individuals to the study. This study will assess the effects of Moodbuster on preventing depression and barriers and facilitators of implementing such an intervention in a UK primary care population. It is hypothesised that the intervention group will display reduced depression symptoms and incidence, reduced service use, and improved quality of life, and the intervention will be acceptable to a UK primary care population.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
290

participants targeted

Target at P75+ for not_applicable depression

Timeline
Completed

Started Oct 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 23, 2019

Completed
Same day until next milestone

Study Start

First participant enrolled

October 23, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 25, 2019

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2020

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2021

Completed
Last Updated

November 13, 2019

Status Verified

November 1, 2019

Enrollment Period

1 year

First QC Date

October 23, 2019

Last Update Submit

November 8, 2019

Conditions

Keywords

DepressionAnxietyPreventionPublic Mental HealthPrimary Care

Outcome Measures

Primary Outcomes (2)

  • Depression Symptoms (Patient Health Questionnaire, 9-item)

    Difference in self-reported depression symptoms between intervention and control groups. The PHQ-9 is formed of nine items, each item is scored from 0-3 (0 = not at all; 3 = nearly every day) yielding a total score between 0 and 27. Higher scores are associated with decreased functional status and increased symptom-related difficulties.

    6 months

  • Depression Symptoms (Patient Health Questionnaire, 9-item)

    Difference in self-reported depression symptoms between intervention and control groups. The PHQ-9 is formed of nine items, each item is scored from 0-3 (0 = not at all; 3 = nearly every day) yielding a total score between 0 and 27. Higher scores are associated with decreased functional status and increased symptom-related difficulties.

    9 months

Secondary Outcomes (9)

  • Depression Onset (Beck Depression Inventory-II)

    9 months

  • Anxiety Symptoms (Generalised Anxiety Disorder Assessment, 7-item)

    6 months

  • Anxiety Symptoms (Generalised Anxiety Disorder Assessment, 7-item)

    9 months

  • Quality of Life (EQ-5D-5L)

    6 months

  • Quality of Life (EQ-5D-5L)

    9 months

  • +4 more secondary outcomes

Study Arms (2)

Intervention

EXPERIMENTAL

Guided Cognitive Behavioural Therapy based app

Other: Moodbuster

Care as usual

NO INTERVENTION

Care as usual

Interventions

Moodbuster intervention comprises three elements: (1) a web-based interface providing the patients access to CBT therapies, (2) a web-based portal for the trial co-ordinator and researchers, where they can view participation, amend modules and send login codes, (3) a mobile phone component which enables daily EMA monitoring of mood state, cognitions, activities, social interaction, and sleep. The mobile application will be used to capture EMA data.

Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 or above
  • Willing and able to give informed consent for participation
  • Have sub-threshold mild to moderate symptoms of depression (PHQ-9 scores of 5-9)
  • Access to the internet
  • In possession of a mobile smartphone (Android) and computer
  • In possession of an e-mail address

You may not qualify if:

  • Currently, or has ever, met DSM-IV criteria for major depression, bipolar disorder, substance dependence, or a psychotic disorder
  • Has had a major depressive episode (meeting DSM-IV criteria) as measured by the BDI-II
  • Is currently receiving psychotherapy, on a waiting list for psychotherapy, or received psychotherapy in the last six months for any mental health problem
  • Is unable to speak, read, or write in English
  • Has started a course of antidepressants within the last six weeks
  • Endorsement of PHQ item 9 "thoughts you would be better off dead, or of hurting yourself in some way"

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Manchester

Manchester, Greater Manchester, M13 9PL, United Kingdom

RECRUITING

Related Publications (15)

  • Buntrock C, Ebert DD, Lehr D, Smit F, Riper H, Berking M, Cuijpers P. Effect of a Web-Based Guided Self-help Intervention for Prevention of Major Depression in Adults With Subthreshold Depression: A Randomized Clinical Trial. JAMA. 2016 May 3;315(17):1854-63. doi: 10.1001/jama.2016.4326.

    PMID: 27139058BACKGROUND
  • Chisholm D, Sweeny K, Sheehan P, Rasmussen B, Smit F, Cuijpers P, Saxena S. Scaling-up treatment of depression and anxiety: a global return on investment analysis. Lancet Psychiatry. 2016 May;3(5):415-24. doi: 10.1016/S2215-0366(16)30024-4. Epub 2016 Apr 12.

    PMID: 27083119BACKGROUND
  • Ustun TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJ. Global burden of depressive disorders in the year 2000. Br J Psychiatry. 2004 May;184:386-92. doi: 10.1192/bjp.184.5.386.

    PMID: 15123501BACKGROUND
  • Gun SY, Titov N, Andrews G. Acceptability of Internet treatment of anxiety and depression. Australas Psychiatry. 2011 Jun;19(3):259-64. doi: 10.3109/10398562.2011.562295.

    PMID: 21682626BACKGROUND
  • Gilbody S, Brabyn S, Lovell K, Kessler D, Devlin T, Smith L, Araya R, Barkham M, Bower P, Cooper C, Knowles S, Littlewood E, Richards DA, Tallon D, White D, Worthy G; REEACT collaborative. Telephone-supported computerised cognitive-behavioural therapy: REEACT-2 large-scale pragmatic randomised controlled trial. Br J Psychiatry. 2017 May;210(5):362-367. doi: 10.1192/bjp.bp.116.192435. Epub 2017 Mar 2.

    PMID: 28254959BACKGROUND
  • Deady M, Choi I, Calvo RA, Glozier N, Christensen H, Harvey SB. eHealth interventions for the prevention of depression and anxiety in the general population: a systematic review and meta-analysis. BMC Psychiatry. 2017 Aug 29;17(1):310. doi: 10.1186/s12888-017-1473-1.

    PMID: 28851342BACKGROUND
  • Christensen H, Batterham P, Mackinnon A, Griffiths KM, Kalia Hehir K, Kenardy J, Gosling J, Bennett K. Prevention of generalized anxiety disorder using a web intervention, iChill: randomized controlled trial. J Med Internet Res. 2014 Sep 2;16(9):e199. doi: 10.2196/jmir.3507.

    PMID: 25270886BACKGROUND
  • Clarke G, Reid E, Eubanks D, O'Connor E, DeBar LL, Kelleher C, Lynch F, Nunley S. Overcoming depression on the Internet (ODIN): a randomized controlled trial of an Internet depression skills intervention program. J Med Internet Res. 2002 Dec;4(3):E14. doi: 10.2196/jmir.4.3.e14.

    PMID: 12554545BACKGROUND
  • Cukrowicz KC, Joiner TE. Computer-based intervention for anxious and depressive symptoms in a non-clinical population. Cognit Ther Res [Internet]. Springer US; 2007 [cited 2018 Aug 3];31:677-93. Available from: http://link.springer.com/10.1007/s10608-006-9094-x

    BACKGROUND
  • Levin ME, Pistorello J, Seeley JR, Hayes SC. Feasibility of a prototype web-based acceptance and commitment therapy prevention program for college students. J Am Coll Health. 2014;62(1):20-30. doi: 10.1080/07448481.2013.843533.

    PMID: 24313693BACKGROUND
  • Imamura K, Kawakami N, Furukawa TA, Matsuyama Y, Shimazu A, Umanodan R, Kawakami S, Kasai K. Effects of an Internet-based cognitive behavioral therapy (iCBT) program in Manga format on improving subthreshold depressive symptoms among healthy workers: a randomized controlled trial. PLoS One. 2014 May 20;9(5):e97167. doi: 10.1371/journal.pone.0097167. eCollection 2014.

    PMID: 24844530BACKGROUND
  • Lintvedt OK, Griffiths KM, Sorensen K, Ostvik AR, Wang CE, Eisemann M, Waterloo K. Evaluating the effectiveness and efficacy of unguided internet-based self-help intervention for the prevention of depression: a randomized controlled trial. Clin Psychol Psychother. 2013 Jan-Feb;20(1):10-27. doi: 10.1002/cpp.770. Epub 2011 Sep 2.

    PMID: 21887811BACKGROUND
  • Spek V, Cuijpers P, Nyklicek I, Smits N, Riper H, Keyzer J, Pop V. One-year follow-up results of a randomized controlled clinical trial on internet-based cognitive behavioural therapy for subthreshold depression in people over 50 years. Psychol Med. 2008 May;38(5):635-9. doi: 10.1017/S0033291707002590. Epub 2008 Jan 21.

    PMID: 18205965BACKGROUND
  • Musiat P, Conrod P, Treasure J, Tylee A, Williams C, Schmidt U. Targeted prevention of common mental health disorders in university students: randomised controlled trial of a transdiagnostic trait-focused web-based intervention. PLoS One. 2014 Apr 15;9(4):e93621. doi: 10.1371/journal.pone.0093621. eCollection 2014.

    PMID: 24736388BACKGROUND
  • Morgan AJ, Jorm AF, Mackinnon AJ. Email-based promotion of self-help for subthreshold depression: Mood Memos randomised controlled trial. Br J Psychiatry. 2012 May;200(5):412-8. doi: 10.1192/bjp.bp.111.101394. Epub 2012 Mar 22.

    PMID: 22442102BACKGROUND

Related Links

MeSH Terms

Conditions

DepressionAnxiety Disorders

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorMental Disorders

Study Officials

  • Kathryn M Abel, PhD

    University of Manchester

    PRINCIPAL INVESTIGATOR
  • Antonis Kousoulis, MD

    Mental Health Foundation

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The study will follow a two-armed randomised controlled, single-blind, parallel group, wait-list control design. Individuals with mild-moderate symptoms of depression who do not have a diagnosis of depression are invited to participate
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 23, 2019

First Posted

October 25, 2019

Study Start

October 23, 2019

Primary Completion

November 1, 2020

Study Completion

April 1, 2021

Last Updated

November 13, 2019

Record last verified: 2019-11

Data Sharing

IPD Sharing
Will share

To share with other researchers, upon request, anonymised and encrypted individual patient data that underlies results from any resulting academic publications.

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE
Time Frame
Six months through 10 years following publication.

Locations